Ginkgo Bioworks DNA EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
Plus components not separately reported this period.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's EBIT?
- Ginkgo Bioworks (DNA) reported EBIT of -$71.37M in Q1 2026.
- How has Ginkgo Bioworks's EBIT changed year-over-year?
- Ginkgo Bioworks's EBIT increased by 11.9% year-over-year, from -$80.97M to -$71.37M.
- What is the long-term trend for Ginkgo Bioworks's EBIT?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's EBIT has grown at a -36.0% compound annual growth rate (CAGR), from -$1.83B to -$307.28M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.